GotoBiopharm Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 893

Employees

  • Stock Symbol
  • 300966

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $3.03
  • (As of Friday Closing)

GotoBiopharm General Information

Description

Hubei Goto Biopharm Group Co Ltd is engaged in the research, development, production and sales of steroidal drug raw materials. The company's main products are starting materials, intermediates and active pharmaceutical ingredients required for the production of steroid drugs.

Contact Information

Formerly Known As
Yicheng Gongtong Pharmaceutical Co., Ltd.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 5th Floor, East Gate of Building #2, Servo-industrial Park
  • 1st Qilin Road
  • Xiangyang, Hubei 441000
  • China
+86 0710
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • 5th Floor, East Gate of Building #2, Servo-industrial Park
  • 1st Qilin Road
  • Xiangyang, Hubei 441000
  • China
+86 0710

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GotoBiopharm Stock Performance

As of 20-Nov-2026, GotoBiopharm’s stock price is $3.03. Its current market cap is $349M with 115M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.03 $3.27 $2.68 - $4.80 $349M 115M 2.28M -$0.11

GotoBiopharm Financials Summary

As of 30-Sep-2026, GotoBiopharm has a trailing 12-month revenue of $96.6M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 639,441 504,597 388,804 467,100
Revenue 96,582 84,293 74,782 80,058
EBITDA (9,018) 7,945 2,812 8,251
Net Income (13,013) (10,201) (3,845) 3,252
Total Assets 440,788 407,429 382,170 345,307
Total Debt 203,165 185,695 155,005 110,844
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GotoBiopharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GotoBiopharm‘s full profile, request access.

Request a free trial

GotoBiopharm Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore GotoBiopharm‘s full profile, request access.

Request a free trial

GotoBiopharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GotoBiopharm Investments (1)

GotoBiopharm’s most recent deal was a Joint Venture with Huahai Gongtong.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Huahai Gongtong Joint Venture Pharmaceuticals
To view GotoBiopharm’s complete investments history, request access »

GotoBiopharm ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view GotoBiopharm’s complete esg history, request access »

GotoBiopharm FAQs

  • When was GotoBiopharm founded?

    GotoBiopharm was founded in 2006.

  • Where is GotoBiopharm headquartered?

    GotoBiopharm is headquartered in Xiangyang, China.

  • What is the size of GotoBiopharm?

    GotoBiopharm has 893 total employees.

  • What industry is GotoBiopharm in?

    GotoBiopharm’s primary industry is Pharmaceuticals.

  • Is GotoBiopharm a private or public company?

    GotoBiopharm is a Public company.

  • What is GotoBiopharm’s stock symbol?

    The ticker symbol for GotoBiopharm is 300966.

  • What is the current stock price of GotoBiopharm?

    As of 20-Nov-2026 the stock price of GotoBiopharm is $3.03.

  • What is the current market cap of GotoBiopharm?

    The current market capitalization of GotoBiopharm is $349M.

  • What is GotoBiopharm’s current revenue?

    The trailing twelve month revenue for GotoBiopharm is $96.6M.

  • What is GotoBiopharm’s annual earnings per share (EPS)?

    GotoBiopharm’s EPS for 12 months was -$0.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process